Magazine

Last edition
January-February 2025

Home › Renewable energy ›Shree Ganesh Remedies Commissions 2 MW Captive Solar Plant in Gujarat

Shree Ganesh Remedies Commissions 2 MW Captive Solar Plant in Gujarat

Gujarat-based pharmaceutical company Shree Ganesh Remedies Ltd. has commissioned a 2 MW solar power plant in Gujarat, covering 70 percent of its power needs. The project is expected to generate annual savings of approximately INR 2 crore in electricity expenses.

March 26, 2025. By Mrinmoy Dey

Gujarat-based pharmaceutical company Shree Ganesh Remedies Ltd. (SGRL) has commissioned a 2 MW solar power plant with auto-tracker modules on leased land in Gujarat furthering its commitment to sustainability.

The energy generated will be used for captive consumption by the company and it will be able to cover about 70 percent of the company’s power requirement.

The project is expected to generate annual savings of approximately INR 2 crore in electricity expenses and reinforces the company's commitment to sustainable manufacturing practices, the company stated in a regulatory filing.

“Our primary source of carbon footprint stems from the utilisation of purchased electricity and fuel. Although we cannot replace electricity with alternative forms of power, thus we have opted to progressively transition the source of our electricity from conventionally generated to cleaner and more efficient renewable resources,” the company stated in its SDG Progress Report 2023.

It further added that the company aims to make the entire process to be operated by green energy by 2030. Shree Ganesh Remedies has set a global carbon ambition to be carbon neutral in the year 2024-25, carbon negative in the calendar year 2026-27 and net zero till the financial year 2050.

In the recent past, pharmaceutical companies have increased their RE intake. Last week, Supriya Lifescience inaugurated a state-of-the-art (SOTA) 5 MWp solar power facility in Nanded District, Maharashtra.

Last month, Hyderabad-based Aurobindo Pharma signed a power purchase agreement with Swarnaaskshu Solar Power to procure solar energy under a captive arrangement. It will be investing up to INR 10.40 crore for a 26 percent stake in the company's planned 30 MW AC (40 MW DC) solar plant in Telangana.

In February 2025, Mumbai-based Aarti Drugs partnered with Prozeal Green Energy to procure solar power through a captive arrangement. The company picked up a 26.25 percent stake in an SPV for INR 8.05 crore to develop a 24.40 MWp solar power plant.

In January 2025, Ahmedabad-based pharmaceutical company Concord Biotech announced that it will procure 9.9 MW wind-solar hybrid power from Clean Max Enviro Energy Solutions (CleanMax) for its manufacturing plant located at Dholka, Gujarat through a captive arrangement.

In October 2024, Bengaluru-based Strides Pharma invested INR 1.61 crore for a 2.48 percent stake in AMPIN Energy C&I One to procure solar power for its Chennai facility via a group captive arrangement.

Tags:

Solar PV

Shree Ganesh Remedies

Captive Solar Power

Captive solar plant in Gujarat

Auto-tracker solar power plant

Solarising pharma sector